Related Experiment Videos
MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry
M M Iravani1, R Muscat, Z L Kruk
1Neurodegenerative Disease Research Centre, Pharmacology Group, Kings College London, UK. m.iravani@kcl.ac.uk
Synapse (New York, N.Y.)
|May 26, 1999
Summary
This study found that MK-801 potentiated serotonin (5-HT) release in brain slices, while NMDA receptor antagonists CPP and NMDA did not affect it. These findings suggest N-methyl-D-aspartate receptors do not modulate 5-HT release.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- Serotonin (5-HT) plays a crucial role in regulating mood and behavior.
- N-methyl-D-aspartate (NMDA) receptors are implicated in various neurological processes.
- Understanding the interaction between NMDA receptors and 5-HT release is vital for developing new therapeutics.
Purpose of the Study:
- To compare the effects of a noncompetitive NMDA receptor antagonist, dizocilpine ((+)-MK-801), and a competitive NMDA antagonist, CPP, on electrically evoked 5-HT release.
- To investigate the role of NMDA receptors in the modulation of 5-HT release in specific brain regions (SNr and DRN).
- To explore potential interactions between MK-801, fluvoxamine, and 5-HT release.
Main Methods:
- Utilized fast cyclic voltammetry (FCV) to measure electrically evoked 5-HT release in brain slices.
- Administered MK-801 and CPP to substantia nigra pars reticulata (SNr) and dorsal raphe nucleus (DRN) slices.
- Assessed the effects of MK-801 and fluvoxamine on 5-HT release, including pre-exposure and co-administration studies.
Main Results:
- MK-801 concentration-dependently potentiated 5-HT release in the SNr and DRN.
- CPP and NMDA had no significant effect on electrically evoked 5-HT release.
- MK-801 and fluvoxamine both potentiated 5-HT release, with MK-801 inhibiting fluvoxamine's enhancing effect.
- MK-801 and fluvoxamine administration significantly increased T1/2 values for 5-HT release.
Conclusions:
- The potentiation of 5-HT release by MK-801 and the lack of effect by CPP or NMDA suggest NMDA receptors are not involved in modulating 5-HT release.
- MK-801 and fluvoxamine may interact at the level of the 5-HT transporter, influencing 5-HT release.
- These findings contribute to understanding the complex neurochemical pathways involved in serotonin regulation.